Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

NSE/INFINIUM stock hub

NSE/INFINIUM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/INFINIUMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.4B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/INFINIUM

In the news

Latest news · NSE/INFINIUM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E35.4

P25 24.8P50 35.9P75 56.9

ROE9.1

P25 6.3P50 13.6P75 18.1

ROIC8

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/INFINIUM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

199

Groups with data

Currency

INR

Showing 199 of 199 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	144
Employees Change	26%
Employees Change Percent	22.03
Enterprise value	INR 3.6B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	INE0MRE01011
Last refreshed	2026-05-10
Market cap	INR 3.4B
Price	INR 215
Price currency	INR
Rev Per Employee	10,887,425.83x
Sector	Healthcare
Sic	2833
Symbol	nse/INFINIUM
Website	https://infiniumpharmachem.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.79%
EV Earnings	38.07x
EV/EBIT	23.39x
EV/EBITDA	19.18x
EV/FCF	-11.61x
EV/Sales	2.27x
FCF yield	-9.14%
P/B ratio	2.56x
P/E ratio	35.44x
P/S ratio	2.14x
PE Ratio3 Y	43.17x
PE Ratio5 Y	37.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	9.69%
EBITDA Margin	11.82%
Gross margin	25.78%
Gross Profit	INR 404.2M
Gross Profit Growth	6.69%
Gross Profit Growth Q	14.08%
Gross Profit Growth3 Y	8.5%
Gross Profit Growth5 Y	4.01%
Net Income	INR 93.4M
Net Income Growth	-1.67%
Net Income Growth Q	27.13%
Net Income Growth3 Y	-6.16%
Net Income Growth5 Y	-0.32%
Pretax Margin	8.57%
Profit Margin	5.96%
Profit Per Employee	INR 648,619
ROA	5.87
Roa5y	11.36
ROCE	10.5
ROE	9.08
Roe5y	39.91
ROIC	7.97
Roic5y	23.14

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-24.64%
Cagr3y	30.71%
EPS Growth	-11.18
EPS Growth Q	13.25
EPS Growth3 Y	-17
EPS Growth5 Y	-8.26
OCF Growth Q	-88.14%
Revenue Growth	-0.23x
Revenue Growth Q	1.29x
Revenue Growth3 Y	4.94x
Revenue Growth5 Y	6.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 0.97
Assets	INR 1.9B
Cash	INR 148.9M
Current Assets	INR 1.3B
Current Liabilities	INR 448.4M
Debt	INR 191.5M
Debt EBITDA	INR 1.03
Debt Equity	INR 0.15
Debt FCF	INR -0.63
Equity	INR 1.3B
Interest Coverage	6.12
Liabilities	INR 586M
Long Term Assets	INR 595.7M
Long Term Liabilities	INR 137.5M
Net Cash	INR -42.6M
Net Cash By Market Cap	INR -1.27
Net Debt EBITDA	INR 0.23
Net Debt Equity	INR 0.03
Tangible Book Value	INR 1.1B
Tangible Book Value Per Share	INR 71.42
WACC	6.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.9
Inventory Turnover	2.74
Net Working Capital	INR 895.2M
Quick ratio	1.34
Working Capital	INR 852.5M
Working Capital Turnover	INR 2.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.71%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-24.63%
200-day SMA	238.2
3Y total return	123.38%
50-day SMA	208.6
50-day SMA vs 200-day SMA	50under200
All Time High	392.5
All Time High Change	-45.22%
All Time High Date	2024-10-04
All Time Low	70.75
All Time Low Change	203.89%
All Time Low Date	2023-04-17
ATR	7.83
Beta	0.36
Beta1y	0.23
Beta2y	0.77
Ch YTD	-3.54
High	218.5
High52	337
High52 Date	2025-05-26
High52ch	-36.2%
Low	213
Low52	189.4
Low52 Date	2026-03-30
Low52ch	13.52%
Ma50ch	3.06%
Price vs 200-day SMA	-9.75%
RSI	54.85
RSI Monthly	48.68
RSI Weekly	45.59
Sharpe ratio	-0.07x
Sortino ratio	0.05
Total Return	-10.71%
Tr YTD	-3.54
Tr1m	4.62%
Tr1w	1.9%
Tr3m	-2.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 152M
Operating Income Growth	14.54
Operating Income Growth Q	27.7
Operating Income Growth3 Y	-1.47
Operating Income Growth5 Y	0.65
Operating margin	9.69

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,515,470%
Net Borrowing	82,094,670
Shares Insiders	51.77%
Shares Out	15,583,120
Shares Qo Q	2.73%
Shares Yo Y	10.71%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR -306.3M
Average Volume	3,250x
Bv Per Share	73.59
CAPEX	INR 58.3M
Ch1m	4.62
Ch1w	1.9
Ch1y	-24.63
Ch3m	-2.27
Ch3y	123.4
Ch6m	-18.84
Change	0.23%
Change From Open	-1.6
Close	214.5
Days Gap	1.86
Depreciation Amortization	33,381,350
Dollar Volume	645,000
Earnings Date	2026-05-22
EBIT	INR 152M
EBITDA	INR 185.4M
EPS	INR 6.07
F Score	4
FCF	INR -306.3M
FCF EV Yield	-8.61x
FCF Per Share	INR -19.66
Financing CF	337,285,710
Fiscal Year End	March
Founded	2,003
Goodwill	33,945,000
Graham Number	100.22757
Graham Upside	-53.38
Income Tax	INR 38.9M
Investing CF	18,644,660
Is Primary Listing	1
Last Earnings Date	2026-02-12
Last Report Date	2025-09-30
Last Split Date	2023-09-13
Last Split Type	Forward
Lynch Fair Value	INR 30.33
Lynch Upside	-85.89
Ma150	227.7
Ma150ch	-5.58%
Ma20	211.5
Ma20ch	1.64%
Net CF	-8,666,500
Next Earnings Date	2026-05-22
Open	218.5
Position In Range	36.36
Ppne	249,142,000
Price Date	2026-05-08
Price EBITDA	INR 18.07
Ptbv Ratio	3.01
Relative Volume	0.86x
Revenue	1,567,789,320x
Tax By Revenue	2.48x
Tax Rate	29%
Tr6m	-18.84%
Volume	3,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/INFINIUM pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/INFINIUM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/INFINIUM?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+51.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+10.7%

Negative means the company is buying back shares.

Technical

NSE/INFINIUM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.9

Neutral momentum band

Price vs 200-day MA

-9.8%

50/200-day relationship not available

Beta (5Y)

0.36

Less volatile than the market

Sharpe ratio

-0.07

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/INFINIUM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/INFINIUM stock rating?

nse/INFINIUM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/INFINIUM analysis?

The full report lives at /stocks/nse/INFINIUM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/INFINIUM?

The latest report frames nse/INFINIUM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/INFINIUM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.